{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:10:50Z","timestamp":1793661050285,"version":"4.5.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["NCC-2210980"],"award-info":[{"award-number":["NCC-2210980"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","award":["NCC-2212470"],"award-info":[{"award-number":["NCC-2212470"]}],"id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008962","name":"Korean Society of Gastroenterology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbadis.2024.167625","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T17:36:31Z","timestamp":1734284191000},"page":"167625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer"],"prefix":"10.1016","volume":"1871","author":[{"given":"Jung Won","family":"Chun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Shon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Eun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Rim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunshin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Myung","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Rae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Hyun","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Young","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Kon","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2174-9726","authenticated-orcid":false,"given":"Sang Hyub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7571-9958","authenticated-orcid":false,"given":"Yun-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2024.167625_bb0005","first-page":"10","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors, world","volume":"10","author":"Rawla","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.bbadis.2024.167625_bb0010","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167625_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.688377","article-title":"The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy","volume":"11","author":"Principe","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2024.167625_bb0020","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s12885-021-08277-7","article-title":"Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approach","volume":"21","author":"Chun","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2024.167625_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","article-title":"State-of-the-art strategies for targeting the DNA damage response in cancer","volume":"16","author":"Pilie","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2024.167625_bb0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/j.gastro.2020.09.043","article-title":"Targeting DNA damage response and replication stress in pancreatic cancer","volume":"160","author":"Dreyer","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2024.167625_bb0035","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/gutjnl-2019-319984","article-title":"DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives","volume":"70","author":"Perkhofer","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2024.167625_bb0040","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrm.2017.67","article-title":"The essential kinase ATR: ensuring faithful duplication of a challenging genome","volume":"18","author":"Saldivar","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2024.167625_bb0045","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1158\/1078-0432.CCR-15-0479","article-title":"Molecular pathways: targeting ATR in cancer therapy","volume":"21","author":"Karnitz","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167625_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092110","article-title":"Maintenance therapy for ATM-deficient pancreatic cancer by multiple DNA damage response interferences after platinum-based chemotherapy","volume":"9","author":"Roger","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2024.167625_bb0055","article-title":"Oxaliplatin and its derivatives \u2013 an overview","volume":"497","author":"O\u2019Dowd","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.bbadis.2024.167625_bb0060","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.bbadis.2024.167625_bb0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fphar.2020.00343","article-title":"The drug-resistance mechanisms of five platinum-based antitumor agents","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2024.167625_bb0070","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","article-title":"Platinum resistance: the role of DNA repair pathways","volume":"14","author":"Martin","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167625_bb0075","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1158\/1535-7163.MCT-14-0636","article-title":"Tumor-related molecular mechanisms of oxaliplatin resistance","volume":"14","author":"Martinez-Balibrea","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbadis.2024.167625_bb0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3389\/fonc.2019.00875","article-title":"Development of patient-derived preclinical platform for metastatic pancreatic cancer: PDOX and a subsequent organoid model system using percutaneous biopsy samples","volume":"9","author":"Choi","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2024.167625_bb0085","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.3853","article-title":"Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs","volume":"13","author":"Hafner","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbadis.2024.167625_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/srep25523","article-title":"BRAID: a unifying paradigm for the analysis of combined drug action","volume":"6","author":"Twarog","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2024.167625_bb0095","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2024.167625_bb0100","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1093\/nar\/gkt304","article-title":"Clustered DNA damage induces pan-nuclear H2AX phosphorylation mediated by ATM and DNA-PK","volume":"41","author":"Meyer","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2024.167625_bb0105","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1038\/s41598-021-88296-3","article-title":"Detection and quantification of gamma-H2AX using a dissociation enhanced lanthanide fluorescence immunoassay","volume":"11","author":"Noubissi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2024.167625_bb0110","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S0959-8049(22)01066-8","article-title":"Optimization of treatment schedule for the ATR inhibitor elimusertib (BAY 1895344) in preclinical tumor models","volume":"174","author":"Wengner","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbadis.2024.167625_bb0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/1535-7163.MCT-19-0019","article-title":"The novel ATR inhibitor BAY 1895344 is efficacious as monotherapy and combined with DNA damage-inducing or repair-compromising therapies in preclinical cancer models","volume":"19","author":"Wengner","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbadis.2024.167625_bb0120","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1158\/1535-7163.MCT-20-1026","article-title":"Novel and highly potent ATR inhibitor M4344 kills cancer cells with replication stress, and enhances the chemotherapeutic activity of widely used DNA damaging agents","volume":"20","author":"Jo","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbadis.2024.167625_bb0125","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"U. Groupe Tumeurs Digestives of, P. Intergroup, FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2024.167625_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73525-y","article-title":"The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data","volume":"10","author":"Bengtsson","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2024.167625_bb0135","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/s41416-022-01946-9","article-title":"CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer","volume":"127","author":"Hsieh","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbadis.2024.167625_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153619","article-title":"Coexisting molecular determinants of acquired oxaliplatin resistance in human colorectal and ovarian cancer cell lines","volume":"20","author":"Noordhuis","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2024.167625_bb0145","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41571-024-00863-5","article-title":"Targeting ATR in patients with cancer","volume":"21","author":"Ngoi","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2024.167625_bb0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/2159-8290.CD-20-0868","article-title":"First-in-human trial of the oral ataxia telangiectasia and RAD3-related (ATR) inhibitor BAY 1895344 in patients with advanced solid tumors","volume":"11","author":"Yap","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbadis.2024.167625_bb0155","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1038\/s41467-021-25904-w","article-title":"A replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer","volume":"12","author":"Konstantinopoulos","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2024.167625_bb0160","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1158\/1078-0432.CCR-16-0083","article-title":"Achieving precision death with cell-cycle inhibitors that target DNA replication and repair","volume":"23","author":"Lin","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167625_bb0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41389-018-0056-4","article-title":"CDKN2A inhibits formation of homotypic cell-in-cell structures","volume":"7","author":"Liang","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbadis.2024.167625_bb0170","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nm.4292","article-title":"HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures","volume":"23","author":"Davies","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2024.167625_bb0175","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1158\/1078-0432.CCR-15-2477","article-title":"Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple-negative breast cancer","volume":"22","author":"Telli","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167625_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121889","article-title":"The influence of PARP, ATR, CHK1 inhibitors on premature mitotic entry and genomic instability in high-grade serous BRCA(MUT) and BRCA(WT) ovarian cancer cells","volume":"11","author":"Gralewska","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2024.167625_bb0185","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.molcel.2022.12.031","article-title":"Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control","volume":"83","author":"Concannon","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2024.167625_bb0190","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s13402-020-00552-2","article-title":"Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy","volume":"43","author":"Zhu","year":"2020","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.bbadis.2024.167625_bb0195","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1158\/0008-5472.CAN-18-2807","article-title":"Inhibition of Ataxia-telangiectasia mutated and RAD3-related (ATR) overcomes oxaliplatin resistance and promotes antitumor immunity in colorectal Cancer","volume":"79","author":"Combes","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2024.167625_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1441935","article-title":"Antagonistic roles of cGAS\/STING signaling in colorectal cancer chemotherapy","volume":"14","author":"Liang","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2024.167625_bb0205","article-title":"Pharmacological boosting of cGAS activation sensitizes chemotherapy by enhancing antitumor immunity","volume":"42","author":"Liu","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2024.167625_bb0210","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ymthe.2022.01.044","article-title":"cGAS\/STING cross-talks with cell cycle and potentiates cancer immunotherapy","volume":"30","author":"Long","year":"2022","journal-title":"Mol. Therapy"},{"key":"10.1016\/j.bbadis.2024.167625_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado4618","article-title":"ATR inhibition activates cancer cell cGAS\/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer","volume":"10","author":"Taniguchi","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbadis.2024.167625_bb0220","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nature03884","article-title":"The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor","volume":"436","author":"Gasser","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2024.167625_bb0225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1074-7613(02)00333-3","article-title":"The role of the NKG2D immunoreceptor in immune cell activation and natural killing","volume":"17","author":"Jamieson","year":"2002","journal-title":"Immunity"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924006197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443924006197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:15:06Z","timestamp":1772457306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443924006197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0925443924006197"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167625","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2024.167625","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167625"}}